Regional Cancer Care Associates LLC

Clinical research site in East Brunswick, New Jersey · J2 BRIER HILL CT, EAST BRUNSWICK, NJ 08816 · (732) 390-7750 · Website

Part of Regional Cancer Care Associates

As of July 2026, 1 paid clinical trial is recruiting at Regional Cancer Care Associates LLC in East Brunswick, New Jersey. Active studies at this site focus on Triple Negative Breast Cancer alongside other indications. Compensation typically covers time, travel, and study visits — most studies also offer study-related medical care at no cost to participants.

Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: July 19, 2026.

Recruiting clinical trials at Regional Cancer Care Associates LLC (1)

Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice in Patients With Triple Negative Breast Cancer Who Have Residual Invasive Disease After Surgery and Neoadjuvant Therapy (ASCENT-05/AFT-65 OptimICE-RD/GBG 119/NSABP B-63)

for Triple Negative Breast Cancer

124 locations incl. Birmingham

Sponsor: Gilead Sciences

Sex: All·Age: 18+

Code: NCT05633654·Phase 3·Recruiting·Listed Dec 2022

Apply to this trial

Explore more

Paid clinical trials in East Brunswick, NJ · New Jersey clinical trials

Regional Cancer Care Associates LLC

Recruiting clinical trials at Regional Cancer Care Associates LLC (1)

Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice in Patients With Triple Negative Breast Cancer Who Have Residual Invasive Disease After Surgery and Neoadjuvant Therapy (ASCENT-05/AFT-65 OptimICE-RD/GBG 119/NSABP B-63)

More research sites in East Brunswick

Explore more